KEGG   DRUG: Bepranemab
Entry
D12228                      Drug                                   
Name
Bepranemab (USAN/INN)
Formula
C6482H10008N1702O2045S44
Exact mass
145819.9164
Mol weight
145909.93
Sequence
(Heavy chain)
EVQLQESGPG LVKPSETLSL TCTVSGFSLT SNDIAWIRQP PGKGLEWMGT IWTDGSTNYN
TAVQSRVTIS VDTSKNQFSL KLSSVTAADT AVYYCARHRL YYGAFDYWGQ GTMVTVSSAS
TKGPSVFPLA PCSRSTSEST AALGCLVKDY FPEPVTVSWN SGALTSGVHT FPAVLQSSGL
YSLSSVVTVP SSSLGTKTYT CNVDHKPSNT KVDKRVESKY GPPCPPCPAP EFLGGPSVFL
FPPKPKDTLM ISRTPEVTCV VVDVSQEDPE VQFNWYVDGV EVHNAKTKPR EEQFNSTYRV
VSVLTVLHQD WLNGKEYKCK VSNKGLPSSI EKTISKAKGQ PREPQVYTLP PSQEEMTKNQ
VSLTCLVKGF YPSDIAVEWE SNGQPENNYK TTPPVLDSDG SFFLYSRLTV DKSRWQEGNV
FSCSVMHEAL HNHYTQKSLS LSLGK
(Light chain)
DIVMTQTPLS LSVTPGQPAS ISCRSSQSLE YSDGYTYLEW YLQKPGQSPQ LLIYEVSNRF
SGVPDRFSGS GSGTDFTLKI SRVEAEDVGV YYCFQATHNP YTFGQGTKLE IKRTVAAPSV
FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL
SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
(Disulfide bridge: H22-H95, H132-L219, H145-H201, H224-H'224, H227-H'227, H259-H319, H365-H423, H'22-H'95, H'132-L'219, H'201-H'145, H'259-H'319, H'365-H'423, L23-L93, L139-L199, L'23-L'93, L'139-L'199)
  Type
Peptide
Efficacy
Anti-tau protein antibody
  Type
Monoclonal antibody
Comment
Treatment of progressive supranuclear palsy and Alzheimer's disease
Target
MAPT (TAU) [HSA:4137] [KO:K04380]
  Pathway
hsa04010  MAPK signaling pathway
hsa05010  Alzheimer disease
hsa05022  Pathways of neurodegeneration - multiple diseases
Brite
Target-based classification of drugs [BR:br08310]
 Not elsewhere classified
  Cellular process
   Cytoskeleton
    MAPT (TAU)
     D12228  Bepranemab (USAN/INN)
Other DBs
CAS: 2244960-75-4
PubChem: 497620641
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system